2021 ANMCO意见书:非高密度脂蛋白胆固醇与低密度脂蛋白胆固醇在临床实践中应用

2021-03-01 国外心血管相关专家小组(统称) J Cardiovasc Med (Hagerstown) . 2021 Mar 1.

血液胆固醇是动脉粥样硬化性心血管疾病的中心因素,几十年以来,低密度脂蛋白胆固醇(LDL-C)一直是预测心血管实践的主要生物标志物和降脂治疗的靶点。本文主要讨论了非高密度脂蛋白胆固醇与低密度脂蛋白胆固醇

中文标题:

2021 ANMCO意见书:非高密度脂蛋白胆固醇与低密度脂蛋白胆固醇在临床实践中应用

英文标题:

Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol in clinical practice: ANMCO position paper

发布日期:

2021-03-01

简要介绍:

血液胆固醇是动脉粥样硬化性心血管疾病的中心因素,几十年以来,低密度脂蛋白胆固醇(LDL-C)一直是预测心血管实践的主要生物标志物和降脂治疗的靶点。本文主要讨论了非高密度脂蛋白胆固醇与低密度脂蛋白胆固醇相比作为动脉粥样硬化性疾病的预测因子和治疗靶点的作用。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 ANMCO意见书:非高密度脂蛋白胆固醇与低密度脂蛋白胆固醇在临床实践中应用.pdf)] GetToolGuiderByIdResponse(projectId=1, id=2cfe01c0020689fc, title=2021 ANMCO意见书:非高密度脂蛋白胆固醇与低密度脂蛋白胆固醇在临床实践中应用, enTitle=Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol in clinical practice: ANMCO position paper, guiderFrom=J Cardiovasc Med (Hagerstown) . 2021 Mar 1., authorId=0, author=, summary=血液胆固醇是动脉粥样硬化性心血管疾病的中心因素,几十年以来,低密度脂蛋白胆固醇(LDL-C)一直是预测心血管实践的主要生物标志物和降脂治疗的靶点。本文主要讨论了非高密度脂蛋白胆固醇与低密度脂蛋白胆固醇, cover=https://img.medsci.cn/2021310/1615389648544_2020535.jpg, journalId=0, articlesId=null, associationId=738, associationName=国外心血管相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Mon Mar 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>血液胆固醇是动脉粥样硬化性心血管疾病的中心因素,几十年以来,低密度脂蛋白胆固醇(LDL-C)一直是预测心血管实践的主要生物标志物和降脂治疗的靶点。本文主要讨论了非高密度脂蛋白胆固醇与低密度脂蛋白胆固醇相比作为动脉粥样硬化性疾病的预测因子和治疗靶点的作用。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=2137, tagName=低密度脂蛋白胆固醇)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2137, guiderKeyword=低密度脂蛋白胆固醇, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3264, appHits=169, showAppHits=0, pcHits=771, showPcHits=3095, likes=0, shares=4, comments=9, approvalStatus=1, publishedTime=Thu Mar 11 00:10:14 CST 2021, publishedTimeString=2021-03-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Wed Mar 10 23:20:35 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Wed Jan 03 20:42:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ANMCO意见书:非高密度脂蛋白胆固醇与低密度脂蛋白胆固醇在临床实践中应用.pdf)])
2021 ANMCO意见书:非高密度脂蛋白胆固醇与低密度脂蛋白胆固醇在临床实践中应用.pdf
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1053743, encodeId=8f5d1053e43c8, content=lpa, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b515466016, createdName=ms5000002050027133, createdTime=Wed Sep 22 11:43:02 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051194, encodeId=43d3105119439, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90915537372, createdName=27274, createdTime=Tue Sep 14 16:59:31 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957716, encodeId=691a95e71614, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210227/e8db42e0d8b84c408811ded19b034c6d/180bda7ea82b4e9fa58b5dd03745b934.jpg, createdBy=c6045463797, createdName=DT, createdTime=Fri Apr 16 22:04:31 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957126, encodeId=caca95e1261b, content=三人行,必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入,添加【梅斯医学科研助手WeChat:medsci_2021】邀您进群! 【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。 【入群福利】👉 群内可实时交流病例,提问同行,跨群讨论,每天更新前沿医学资讯和指南共识,每周推出至少1场专业直播,不时共享科研干货,入群即可获得100份SCI写作攻略!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/08ec7710e47c4f6dba6c277207bf00ec/823f09e953ea44188e56b38cd2f16334.jpg, createdBy=ec565230154, createdName=梅干儿, createdTime=Thu Apr 15 00:00:46 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954085, encodeId=11a195408548, content=想看看原文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/40c39b0fd0774a8582ab36eb84b35f5d/fc3bd15004a7420f82aad78c070ac303.jpg, createdBy=cd661537625, createdName=104843, createdTime=Tue Apr 06 07:17:38 CST 2021, time=2021-04-06, status=1, ipAttribution=)]
    2021-09-22 ms5000002050027133

    lpa

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1053743, encodeId=8f5d1053e43c8, content=lpa, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b515466016, createdName=ms5000002050027133, createdTime=Wed Sep 22 11:43:02 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051194, encodeId=43d3105119439, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90915537372, createdName=27274, createdTime=Tue Sep 14 16:59:31 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957716, encodeId=691a95e71614, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210227/e8db42e0d8b84c408811ded19b034c6d/180bda7ea82b4e9fa58b5dd03745b934.jpg, createdBy=c6045463797, createdName=DT, createdTime=Fri Apr 16 22:04:31 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957126, encodeId=caca95e1261b, content=三人行,必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入,添加【梅斯医学科研助手WeChat:medsci_2021】邀您进群! 【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。 【入群福利】👉 群内可实时交流病例,提问同行,跨群讨论,每天更新前沿医学资讯和指南共识,每周推出至少1场专业直播,不时共享科研干货,入群即可获得100份SCI写作攻略!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/08ec7710e47c4f6dba6c277207bf00ec/823f09e953ea44188e56b38cd2f16334.jpg, createdBy=ec565230154, createdName=梅干儿, createdTime=Thu Apr 15 00:00:46 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954085, encodeId=11a195408548, content=想看看原文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/40c39b0fd0774a8582ab36eb84b35f5d/fc3bd15004a7420f82aad78c070ac303.jpg, createdBy=cd661537625, createdName=104843, createdTime=Tue Apr 06 07:17:38 CST 2021, time=2021-04-06, status=1, ipAttribution=)]
    2021-09-14 27274

    积分

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1053743, encodeId=8f5d1053e43c8, content=lpa, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b515466016, createdName=ms5000002050027133, createdTime=Wed Sep 22 11:43:02 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051194, encodeId=43d3105119439, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90915537372, createdName=27274, createdTime=Tue Sep 14 16:59:31 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957716, encodeId=691a95e71614, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210227/e8db42e0d8b84c408811ded19b034c6d/180bda7ea82b4e9fa58b5dd03745b934.jpg, createdBy=c6045463797, createdName=DT, createdTime=Fri Apr 16 22:04:31 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957126, encodeId=caca95e1261b, content=三人行,必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入,添加【梅斯医学科研助手WeChat:medsci_2021】邀您进群! 【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。 【入群福利】👉 群内可实时交流病例,提问同行,跨群讨论,每天更新前沿医学资讯和指南共识,每周推出至少1场专业直播,不时共享科研干货,入群即可获得100份SCI写作攻略!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/08ec7710e47c4f6dba6c277207bf00ec/823f09e953ea44188e56b38cd2f16334.jpg, createdBy=ec565230154, createdName=梅干儿, createdTime=Thu Apr 15 00:00:46 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954085, encodeId=11a195408548, content=想看看原文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/40c39b0fd0774a8582ab36eb84b35f5d/fc3bd15004a7420f82aad78c070ac303.jpg, createdBy=cd661537625, createdName=104843, createdTime=Tue Apr 06 07:17:38 CST 2021, time=2021-04-06, status=1, ipAttribution=)]
    2021-04-16 DT

    积分

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1053743, encodeId=8f5d1053e43c8, content=lpa, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b515466016, createdName=ms5000002050027133, createdTime=Wed Sep 22 11:43:02 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051194, encodeId=43d3105119439, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90915537372, createdName=27274, createdTime=Tue Sep 14 16:59:31 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957716, encodeId=691a95e71614, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210227/e8db42e0d8b84c408811ded19b034c6d/180bda7ea82b4e9fa58b5dd03745b934.jpg, createdBy=c6045463797, createdName=DT, createdTime=Fri Apr 16 22:04:31 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957126, encodeId=caca95e1261b, content=三人行,必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入,添加【梅斯医学科研助手WeChat:medsci_2021】邀您进群! 【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。 【入群福利】👉 群内可实时交流病例,提问同行,跨群讨论,每天更新前沿医学资讯和指南共识,每周推出至少1场专业直播,不时共享科研干货,入群即可获得100份SCI写作攻略!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/08ec7710e47c4f6dba6c277207bf00ec/823f09e953ea44188e56b38cd2f16334.jpg, createdBy=ec565230154, createdName=梅干儿, createdTime=Thu Apr 15 00:00:46 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954085, encodeId=11a195408548, content=想看看原文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/40c39b0fd0774a8582ab36eb84b35f5d/fc3bd15004a7420f82aad78c070ac303.jpg, createdBy=cd661537625, createdName=104843, createdTime=Tue Apr 06 07:17:38 CST 2021, time=2021-04-06, status=1, ipAttribution=)]
    2021-04-15 梅干儿

    三人行,必有我师。 #梅斯医学科研互助群# 欢迎您的加入,添加【梅斯医学科研助手WeChat:medsci_2021】邀您进群! 【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。 【入群福利】👉 群内可实时交流病例,提问同行,跨群讨论,每天更新前沿医学资讯和指南共识,每周推出至少1场专业直播,不时共享科研干货,入群即可获得100份SCI写作攻略!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1053743, encodeId=8f5d1053e43c8, content=lpa, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b515466016, createdName=ms5000002050027133, createdTime=Wed Sep 22 11:43:02 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051194, encodeId=43d3105119439, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90915537372, createdName=27274, createdTime=Tue Sep 14 16:59:31 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957716, encodeId=691a95e71614, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210227/e8db42e0d8b84c408811ded19b034c6d/180bda7ea82b4e9fa58b5dd03745b934.jpg, createdBy=c6045463797, createdName=DT, createdTime=Fri Apr 16 22:04:31 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957126, encodeId=caca95e1261b, content=三人行,必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入,添加【梅斯医学科研助手WeChat:medsci_2021】邀您进群! 【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。 【入群福利】👉 群内可实时交流病例,提问同行,跨群讨论,每天更新前沿医学资讯和指南共识,每周推出至少1场专业直播,不时共享科研干货,入群即可获得100份SCI写作攻略!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/08ec7710e47c4f6dba6c277207bf00ec/823f09e953ea44188e56b38cd2f16334.jpg, createdBy=ec565230154, createdName=梅干儿, createdTime=Thu Apr 15 00:00:46 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954085, encodeId=11a195408548, content=想看看原文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210711/40c39b0fd0774a8582ab36eb84b35f5d/fc3bd15004a7420f82aad78c070ac303.jpg, createdBy=cd661537625, createdName=104843, createdTime=Tue Apr 06 07:17:38 CST 2021, time=2021-04-06, status=1, ipAttribution=)]
    2021-04-06 104843

    想看看原文

    0